Additional clarifications on Healthtech demerger scheme

Apollo Hospitals provided further clarifications on its proposed composite scheme involving Apollo Healthco, Keimed Private, and Apollo Healthtech. Key points: promoter and promoter group will waive director nomination rights if their aggregate shareholding falls below 10 percent, with further waivers tied to lower shareholding thresholds. Board composition norms and independent director requirements for Apollo Healthtech have also been outlined. The scheme aims to separate and independently list Apollo Healthtech.